Research And Markets Research And Markets
0 CHECKOUT

Poland Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3456784
  • November 2015
  • Region: Poland
  • 86 pages
  • Business Monitor International
1 of 4

The Polish healthcare system faces significant reform under the newly elected Law and Justice party. We believe that a transition from Poland's current insurance based healthcare system to a tax financed healthcare system will be broadly positive for all stakeholders, including the pharmaceutical sector, as it will provide a more stable and larger source of revenue. Reimbursement criteria will also be loosened for innovative drugs, which in turn will be beneficial for multinational drugmakers operating in Poland.

Headline Expenditure Projections
- Pharmaceuticals: PLN32.04bn (USD10.15bn) in 2014 to PLN33.39bn (USD8.91bn) in 2015; +4.2% in local currency terms and -12.2% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: PLN111.53bn (USD35.35bn) in 2014 to PLN115.81bn (USD30.92bn) in 2015; +3.8% in local currency terms and -12.5% in US dollar terms. Forecast in line with last quarter.

Note: Product cover images may vary from those shown
2 of 4

Table: Headline Pharmaceuticals & Healthcare Forecasts (Poland 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Poland 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Poland 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Poland 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Poland 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Poland 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Poland 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Poland 2013-2019)

Industry Risk Reward Index

Central And Eastern Europe Risk/Reward Index - Q1 2016

Poland Risk/Reward Index

Rewards

Risks

Regulatory Review

Advertising Regulations

Other Regulatory Developments

Intellectual Property Regime

Pricing And Reimbursement

Pricing Regime

Reimbursement Regime

Market Overview

Healthcare Sector
Table: Civilian Outpatient Facilities, 2002-2009
Table: Healthcare Resources (Poland 2009-2014)
Table: Healthcare Personnel (Poland 2009-2014)
Table: Healthcare Activity (Poland 2009-2014)

Research & Development

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Multinational Market Activity

Pharmaceutical Distribution

Pharmaceutical Retail Sector
Table: Number Of Pharmacies In Poland, 2004-2009

Company Profile

Polpharma

Bioton

Demographic Forecast

Demographic Outlook
Table: Population Headline Indicators (Poland 1990-2025)
Table: Key Population Ratios (Poland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Poland 1990-2025)
Table: Population By Age Group (Poland 1990-2025)
Table: Population By Age Group % (Poland 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Polpharma
Bioton

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Cache